A Pharmacokinetic Analysis and Pharmacogenomic Study of 6-mercaptopurine

  • Sivolapenko G
N/ACitations
Citations of this article
9Readers
Mendeley users who have this article in their library.

Abstract

Background: The efficacy and safety of 6-mercaptopurine (6-MP) therapy rely on the concentration of its metabolites. The aim of the current study is the pharmacokinetic analysis of 6-MP and the detection of its metabolites as well as the role of Thiopurine S-methyl transferase (TPMT), the enzyme associated with 6-MP metabolism, as a pharmacogenomics biomarker.

Cite

CITATION STYLE

APA

Sivolapenko, G. (2015). A Pharmacokinetic Analysis and Pharmacogenomic Study of 6-mercaptopurine. International Journal of Pharmaceutical Sciences and Developmental Research, 002–007. https://doi.org/10.17352/ijpsdr.000002

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free